Clinical Trial Update: A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. [Phase 3]

View source ↗

Summary

A Phase III open-label long-term extension study of Depakote ER in migraine patients who completed or discontinued the prior study due to ineffectiveness; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Abbott | Conditions: Migraines | Phase 3 | Status: COMPLETED